Home
Randomize
Rationale and aim
Study design
Trial Organization
Trial protocol and trial documents
inf consent / letter: Belgium
inf consent / letter: Netherlands
Amphia
Amsterdam UMC
ASZ
Catharina
Erasmus MC
ETZ
Haga
HMC
Isala
LUMC
MST
MUMC
NWZ
Radboud MC
Rijnstate
UMC Utrecht
UMCG
Progress of the trial
News
Contact
Ontslaggegevens / Discharge data
Links
FAQ
Progress of the trial
Study start date: mid 2023
Study end date: mid-end 2026